Target intelligence / Profile preview

Human Immunodeficiency Virus 1 Protease (HIV-1 PR)

Target
HIV-1 PR
Molecular classification
Enzyme, Aspartyl protease, Retroviral protease
01

Overview

Human immunodeficiency virus 1 protease (HIV-1 protease, often abbreviated as HIV-1 PR) is a retroviral aspartyl protease essential for the life cycle of HIV-1, the causative agent of AIDS. It is responsible for cleaving newly synthesized viral polyproteins—specifically Gag and Gag-Pol—at multiple sites to generate mature protein components required for assembling infectious virions. Beyond its role in viral maturation, recent research suggests that HIV-1 PR can also cleave host cell proteins involved in translation regulation, apoptosis, and antiviral responses. This activity may help modulate host cell function to favor viral persistence and immune evasion.

Other names
HIV-1 proteaseHIV protease
02

Mechanism of action

Competitive inhibition of HIV-1 protease, preventing cleavage of viral polyproteins and thus blocking viral maturation

03

Biological functions

Viral maturationCleavage of Gag/Gag-Pol polyproteinsRegulation of translationModulation of apoptosisCounteracting cellular restriction factorsPeptide bond hydrolysis
04

Disease associations

InfectionAIDS
05

Safety considerations

Resistance mutationsFitness costs associated with resistance mutations
06

Interacting drugs

Protease inhibitors (PIs)

Beyond the preview

Go deeper on Human Immunodeficiency Virus 1 Protease (HIV-1 PR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus 1 Protease (HIV-1 PR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call